Communications
[11] Notes: a) The reaction of phenyl ethyl ketene with diphenyla-
cetaldehyde proceeds in moderate to excellent enantioselectivity
in a variety of solvents (e.g., toluene, Et2O, EtOAc, 1,2-
dimethoxyethane, THF, and CH2Cl2; however, not N-methyl-
pyrrolidone); b) Slightly lower ee values were observed at room
temperature; c) Typically, ca. 85% of catalyst 1 can be recovered
at the end of the reaction.
[12] These enol esters are more reactive than the aryl esters produced
by the addition of 2-tert-butylphenol to ketenes (see ref. [4b]).
[13] For other processes catalyzed by 1 that are believed to proceed
through chiral enolate A, see: a) B. L. Hodous, G. C. Fu, J. Am.
Chem. Soc. 2002, 124, 1578 – 1579; b) Ref. [8].
[14] For a pioneering study of the O-acylation of enolates by ketenes,
see: K. Yoshida, Y. Yamashita, Tetrahedron Lett. 1966, 7, 693 –
696.
[15] For a process catalyzed by 1 that is believed to proceed through
an analogous chiral Brønsted base/acid pathway, see ref. [4b].
[16] For a reviewof nonlinear effects in asymmetric catalysis, see:
H. B. Kagan, T. O. Luukas in Comprehensive Asymmetric
Catalysis (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto),
Springer, NewYork, 1999, chapt. 4.1.
[1] For leading references to bioactive a-arylalkanoic acid deriva-
tives, see: a) “Fenvalerate”: The Merck Index, 13th ed., Merck,
Whitehouse Station, NJ, 2001, pp. 710 – 711; b) J. Robichaud, R.
Oballa, P. Prasit, J.-P. Falgueyret, M. D. Percival, G. Wesolowski,
S. B. Rodan, D. Kimmel, C. Johnson, C. Bryant, S. Venkatraman,
E. Setti, R. Mendonca, J. T. Palmer, J. Med. Chem. 2003, 46,
3709 – 3727; c) M. F. Landoni, A. Soraci, Curr. Drug Metab. 2001,
2, 37 – 51; d) C. D. W. Brooks, A. O. Stewart, T. Kolasa, A.
Basha, P. Bhatia, J. D. Ratajczyk, R. A. Craig, D. Gunn, R. R.
Harris, J. B. Bouska, P. E. Malo, R. L. Bell, G. W. Carter, Pure
Appl. Chem. 1998, 70, 271 – 274; e) K. Brune, G. Geisslinger, S.
Menzel-Soglowek, J. Clin. Pharmacol. 1992, 32, 944 – 952;
f) H. R. Sonawane, N. S. Bellur, J. R. Ahuja, D. G. Kulkarni,
Tetrahedron: Asymmetry 1992, 3, 163 – 192; g) J.-P. Rieu, A.
Boucherle, H. Cousse, G. Mouzin, Tetrahedron 1986, 42, 4095 –
4131; h) N. Bodor, R. Woods, C. Raper, P. Kearney, J. J.
Kaminski, J. Med. Chem. 1980, 23, 474 – 480.
[2] For examples of industrial interest in using asymmetric additions
to ketenes to produce arylpropionic acid derivatives, see:
a) R. D. Larsen, E. G. Corley, P. Davis, P. J. Reider, E. J. J.
Grabowski, J. Am. Chem. Soc. 1989, 111, 7650 – 7651; b) C. G. M.
Villa, S. P. Panossian in Chirality in Industry (Eds.: A. N. Collins,
G. N. Sheldrake, J. Crosby), Wiley, NewYork, 1992, chapt. 15;
c) G. P. Stahly, R. M. Starrett in Chirality in Industry II (Eds.:
A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, NewYork,
1997, chapt. 3.
[17] This behavior contrasts with enantioselective additions of 2-tert-
butylphenol to ketenes catalyzed by 1 in which the catalyst
deprotonates the phenol; the mechanism is likely a chiral
Brønsted acid catalyzed pathway (see ref. [4b]).
[18] Owing to the rapidness of the reaction at 08C, this experiment
was conducted at À908C (t1/2 ꢀ 1 h).
[3] For pioneering studies of asymmetric catalysis of this process,
see: a) H. Pracejus, Justus Liebigs Ann. Chem. 1960, 634, 9 – 22;
b) H. Pracejus, H. Mätje, J. Prakt. Chem. 1964, 24, 195 – 205, and
references therein.
[4] For our studies of asymmetric catalysis of this process, see:
a) B. L. Hodous, J. C. Ruble, G. C. Fu, J. Am. Chem. Soc. 1999,
121, 2637 – 2638; b) S. L. Wiskur, G. C. Fu, J. Am. Chem. Soc.
2005, 127, 6176 – 6177.
[5] For reviews of enantioselective protonations of enols/enolates,
see: a) A. Yanagisawa in Comprehensive Asymmetric Catalysis
(Supplement 2) (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto),
Springer, NewYork, 2004, pp. 125 – 132; A. Yanagisawa, H.
Yamamoto in Comprehensive Asymmetric Catalysis (Eds.: E. N.
Jacobsen, A. Pfaltz, H. Yamamoto), Springer, NewYork, 1999,
chapt. 34.2; b) J. Eames, N. Weerasooriya, Tetrahedron: Asym-
metry 2001, 12, 1 – 24; c) C. Fehr in Chirality in Industry II (Eds.:
A. N. Collins, G. N. Sheldrake, J. Crosby), Wiley, NewYork,
1997, chapt. 16; C. Fehr, Angew. Chem. 1996, 108, 2726 – 2748;
Angew. Chem. Int. Ed. Engl. 1996, 35, 2567 – 2587.
[6] For leading references, see: G. C. Fu, Acc. Chem. Res. 2004, 37,
542 – 547.
[7] For a report of the O-acylation of b-ketoesters upon treatment
= =
with excess ketene (O C CH2) and pyridine, see: K. W. Rosen-
mund, G. Kositzke, H. Bach, Chem. Ber. 1959, 92, 494 – 501.
[8] In contrast, treatment of a ketene with catalyst 1 and a non-
enolizable aldehyde (e.g., PhCHO) leads to [2+2] cycloaddition
to generate a b-lactone with good stereoselectivity: J. E. Wilson,
G. C. Fu, Angew. Chem. 2004, 116, 6518 – 6520; Angew. Chem.
Int. Ed. 2004, 43, 6358 – 6360.
[9] Interestingly, under these conditions, catalyst
1 does not
rearrange the enol ester to a 1,3-dicarbonyl compound. For
example, see: I. D. Hills, G. C. Fu, Angew. Chem. 2003, 115,
4051 – 4054; Angew. Chem. Int. Ed. 2003, 42, 3921 – 3924.
[10] General procedure: Under argon, a solution of the ketene
(1.0 equiv) in CHCl3 was added by syringe over 7 min to a
solution of the catalyst (10%) and diphenylacetaldehyde
(1.1 equiv) in CHCl3 at 08C. The resulting solution was stirred
at 08C, and then the reaction was quenched by the addition of
MeOH (1 mL). The solvent was removed by rotary evaporation,
and the residue was purified by column chromatography.
4608 ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2005, 44, 4606 –4608